StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Qiagen N.V.
NYSE:QGEN
Sector
Location
Market Cap
USD 10.51 B
Share Price
USD 48.55
Avg Daily Volume
1,425,331
Change (1 day)
1.23%
Change (1 year)
18.33%
Change (YTD)
9.03%
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 680.21 M
Qiagen N.V. Operating Cash Flow is USD 680.21 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 30.66% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 520.61 M, a -10.21% change year over year.
-
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 579.78 M, a -19.23% change year over year.
-
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 717.78 M, a 25.81% change year over year.
-
Qiagen N.V. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 570.52 M, a 88.90% change year over year.
Competitors
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
Becton, Dickinson and Company
USD 177.50
BDX
+2.00
1.14%
GE HealthCare Technologies Inc.
USD 76.50
GEHC
+0.99
1.31%
Agilent Technologies, Inc.
USD 124.17
A
+2.87
2.37%
Natera, Inc.
USD 163.36
NTRA
+1.61
1.00%
Laboratory Corporation of America Holdings
USD 253.63
LH
-5.44
-2.10%
bioMérieux S.A.
USD 142.27
BIM.PA
+1.98
1.41%
Baxter International Inc.
USD 29.70
BAX
-0.11
-0.37%
Revvity, Inc.
USD 102.40
RVTY
+2.27
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Exact Sciences Corporation
USD 53.32
EXAS
-1.99
-3.60%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Globus Medical, Inc.
USD 57.80
GMED
+0.49
0.85%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.01
0.15%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.26
3347.HK
+0.12
1.91%
Bio-Rad Laboratories, Inc.
USD 259.88
BIO
+6.81
2.69%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
Becton, Dickinson and Company
USD 177.50
BDX
+2.00
1.14%
GE HealthCare Technologies Inc.
USD 76.50
GEHC
+0.99
1.31%
Agilent Technologies, Inc.
USD 124.17
A
+2.87
2.37%
Natera, Inc.
USD 163.36
NTRA
+1.61
1.00%
Laboratory Corporation of America Holdings
USD 253.63
LH
-5.44
-2.10%
bioMérieux S.A.
USD 142.27
BIM.PA
+1.98
1.41%
Baxter International Inc.
USD 29.70
BAX
-0.11
-0.37%
Revvity, Inc.
USD 102.40
RVTY
+2.27
2.27%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
-0.05
-0.62%
Exact Sciences Corporation
USD 53.32
EXAS
-1.99
-3.60%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Globus Medical, Inc.
USD 57.80
GMED
+0.49
0.85%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.01
0.15%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.26
3347.HK
+0.12
1.91%
Bio-Rad Laboratories, Inc.
USD 259.88
BIO
+6.81
2.69%